Related references
Note: Only part of the references are listed.Advancing dementia prevention through effective blood pressure control
Ruth Peters et al.
LANCET NEUROLOGY (2020)
New Treatment Approaches to Modify the Course of Cerebral Small Vessel Diseases
Eric E. Smith et al.
STROKE (2020)
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia A Randomized Clinical Trial
Jeff D. Williamson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
CNS small vessel disease A clinical review
Rocco J. Cannistraro et al.
NEUROLOGY (2019)
Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease A Randomized Trial
Daan L. K. de Jong et al.
HYPERTENSION (2019)
Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions
Ilya M. Nasrallah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The cGMP-Degrading Enzyme Phosphodiesterase-5 (PDE5) in Cerebral Small Arteries of Older People
Ekta Vasita et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial
Gordon W. Blair et al.
ECLINICALMEDICINE (2019)
The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review
Mathilde M. H. Pauls et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease The PRESERVE Randomized Clinical Trial
Iain D. Croall et al.
JAMA NEUROLOGY (2018)
Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension
William B. White et al.
AMERICAN HEART JOURNAL (2018)
Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market
Robert A. Kloner et al.
SEXUAL MEDICINE REVIEWS (2018)
Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy
Ulrich Lindberg et al.
NEUROTHERAPEUTICS (2017)
Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease
Min Sheng et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care)
Jan Willem van Dalen et al.
STROKE (2017)
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial
Mathilde M. H. Pauls et al.
TRIALS (2017)
White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not
Catherine A. Spilling et al.
BMC PULMONARY MEDICINE (2017)
Nitric oxide-sensitive guanylyl cyclase signaling affects CO2-dependent but not pressure-dependent regulation of cerebral blood flow
Shadi Jahshan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2017)
PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
Andrew F. Teich et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Reduced blood flow in normal white matter predicts development of leukoaraiosis
Manya Bernbaum et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Longitudinal Relationship Between Cerebral Small-Vessel Disease and Cerebral Blood Flow The Second Manifestations of Arterial Disease-Magnetic Resonance Study
Pieternella H. van der Veen et al.
STROKE (2015)
Recommended Implementation of Arterial Spin-Labeled Perfusion MRI for Clinical Applications: A Consensus of the ISMRM Perfusion Study Group and the European Consortium for ASL in Dementia
David C. Alsop et al.
MAGNETIC RESONANCE IN MEDICINE (2015)
Regional cerebral blood flow following single-dose and continuous-dose tadalafil after stroke
M. Lorberboym et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Intensive Blood Pressure Lowering Increases Cerebral Blood Flow in Older Subjects With Hypertension
Dinesh Tryambake et al.
HYPERTENSION (2013)
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Carolina Garcia-Barroso et al.
NEUROPHARMACOLOGY (2013)
Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
Ana Garcia-Osta et al.
ACS CHEMICAL NEUROSCIENCE (2012)
PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure Results of a 1-Year, Prospective, Randomized, Placebo-Controlled Study
Marco Guazzi et al.
CIRCULATION-HEART FAILURE (2011)
The effect of sildenafil citrate (Viagra) on cerebral blood flow in patients with cerebrovascular risk factors
M. Lorberboym et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Blood Pressure Lowering with Valsartan Is Associated with Maintenance of Cerebral Blood Flow and Cerebral Perfusion Reserve in Hypertensive Patients with Cerebral Small Vessel Disease
Yasuyuki Kimura et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2010)
Cerebral haemodynamic response or excitability is not affected by sildenafil
Christina Kruuse et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment
J. Richard Jennings et al.
HYPERTENSION (2008)
Hemodynamic Influences of Azelnidipine, a Novel Calcium Channel Blocker, on Cerebral Circulation in Hypertensive Patients with Ischemic White Matter Lesions
Yasuyuki Kimura et al.
HYPERTENSION RESEARCH (2008)
Cerebral perfusion in the elderly with nocturnal blood pressure fall
A. Siennicki-Lantz et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Association of ambulatory blood pressure with ischemic brain injury
Gary L. Schwartz et al.
HYPERTENSION (2007)
Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics
S. Thomas Forgue et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Cardiovascular safety update of tadalafil:: Retrospective analysis of data from placebo-controlled and open-label clinical trials of tadalafil with as needed, three times-per-week or once-a-day dosing
Robert A. Kloner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Tadalafil pharmacokinetics in healthy subjects
ST Forgue et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Circadian periodicity of cerebral blood flow revealed by laser-Doppler flowmetry in awake rats: relation to blood pressure and activity
CA Wauschkuhn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke -: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy
C Dufouil et al.
CIRCULATION (2005)
Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: A randomized controlled trial
FS Nazir et al.
CEREBROVASCULAR DISEASES (2005)
The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke
FS Nazir et al.
JOURNAL OF HYPERTENSION (2004)
Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis
M O'Sullivan et al.
NEUROLOGY (2002)
Twenty-four-hour non-invasive monitoring of systemic haemodynamics and cerebral blood flow velocity in healthy humans
M Diamant et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2002)
Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease
MR Walters et al.
STROKE (2001)
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm
YY Zhang et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2001)
Share Paper
